NGM Biopharmaceuticals Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 04, 2021 / 04:10PM GMT
Ritu Subhalaksmi Baral - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Hi, everyone. Thanks for joining us today at the last day of the Cowen Healthcare Conference in 2021. And thanks for joining us for the NGM fireside chat. I'm covering analyst Ritu Baral. And with us from NGM today, we have CEO David Woodhouse; and CFO, Siobhan Mangini. Thanks, guys, for joining us.

David J. Woodhouse - NGM Biopharmaceuticals, Inc. - CEO & Director

Thanks for the invite. We're always happy to attend the Cowen conference whether virtual or in-person.

Ritu Subhalaksmi Baral - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Yes. So well, hopefully, this is the last virtual. And hope to see everybody in the fall for their conference for those clients on the line.

Questions and Answers:

Ritu Subhalaksmi Baral - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

So let's start with,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot